Schwarz Pharma AG - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Schwarz Pharma AG. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Schwarz Pharma AG. The Group's principal activity is to research, develop, manufacture and market pharmaceuticals. It involves in bulk manufacturing, packaging and material management of pharmaceutical drugs. It specializes in manufacturing solid oral dosage forms and packing with modern blister machines. It also provides raw material and packaging materials for pharmaceutical industries. The drugs are manufactured for the following concerns: Cardiovascular diseases, Gastro intestinal diseases, Urology and Central nervous system related diseases. It operates under the brand names Atmadisc, Deponit, Dycanil, Elantan, Firin, Harzol, Isoket, Naramig, Nipruss and Sita. The Group operates in Germany, Italy, the United Kingdom, the United States, Switzerland, China, Hong Kong and Philippines.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report